3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Conditions
Leukemia, Myeloid, Acute
885
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Hematologic Neoplasms
466
Leukemia, Lymphocytic, Chronic, B-Cell
392
Leukemia
337
Myelodysplastic Syndromes
330
Lymphoma
208
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
146
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Recurrence
138
Neoplasms
135
Leukemia, Myelomonocytic, Chronic
112
Burkitt Lymphoma
93
Lymphoma, Mantle-Cell
92
Lymphoma, Follicular
92
Lymphoma, Large B-Cell, Diffuse
91
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Leukemia, Biphenotypic, Acute
81
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
54
Leukemia, B-Cell
52
Anemia, Refractory, with Excess of Blasts
46
Leukemia, Myeloid, Chronic-Phase
41
Hematologic Diseases
37
Lymphoma, T-Cell
33
Interventions
posaconazole
1
Fluconazole
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Aspergillosis
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled
NCT03349931
2025-11-20
MYCOGENIE
Assistance Publique - Hôpitaux de Paris
Completed
350 enrolled